Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Intracranial Aneurysm
Interventions
PROCEDURE

Stereotactic RadioSurgery (SRS)

"All treatments will be performed using the Gamma Knife Perfexion or Icon system (Elekta). The following treatment parameters will be used:~* The head will be immobilized using a stereotactic Leksell Model G frame, installed using local protocols~* Targeting will be performed by using a stereotactic CTA. No MRI will be performed.~* Only one aneurysm will be treated per patient~* The aneurysm, including its neck, will be contoured and targeted using a combination of 4mm isocenters as deemed appropriate by the treating team~* A prescription dose of 25 Gy at the margin of the target will be used~* The maximal dose on optic pathways will be kept below 10 Gy~* The brainstem 12-Gy volume will be kept below 1cc"

Trial Locations (1)

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Université de Sherbrooke

OTHER

collaborator

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

lead

Dr David Mathieu

OTHER

NCT06047951 - Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial | Biotech Hunter | Biotech Hunter